VANGUARD GROUP INC 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 10:48 am Sale | 2026-03-13 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 0 0.000% | -1,027,089 (Position Closed) | Filing |
| 2026-01-30 2:20 pm Purchase | 2025-12-31 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 1,027,089 5.040% | 78,442 (+8.27%) | Filing |
| 2025-10-31 11:05 am Purchase | 2025-09-30 | 13G | NEKTAR THERAPEUTICS NKTR | VANGUARD GROUP INC | 948,647 4.980% | 145,789 (+18.16%) | Filing |